Differences

This shows you the differences between two versions of the page.

--- chiachen_cheng [2022/05/02 04:22]
liam [Education]
+++ chiachen_cheng [2022/05/02 06:17] (current)
liam [Awards and funding]
@@ Line 10: / Line 10: @@
 She completed her General Psychiatry residency and Child & Adolescent Psychiatry sub-specialization at [[McMaster University]].((//Community Partners.// Lakehead University. Retrieved May 1, 2022, from https://www.lakeheadu.ca/centre/cranhr/people/partners)) She received a Masters of [[Public Health]] from [[Harvard University]].((//Annual Retreat 2011 Biographical Notes.// (2011). Ontario Psychiatric Outreach Program. https://web.archive.org/web/20220502022039/https://www.porticonetwork.ca/documents/366159/1073224/2011+retreat+presenter+bios.pdf/d09b46d7-9d01-486a-8033-e287d7ffced7))
+She subsequently received a two-year postdoctoral fellowship through the [[Canadian Institutes of Health Research]]’s Research in Addictions and Mental Health Policy and Services program.
 ===== Career and Affiliations =====
+==== Ontario Psychiatric Association ====
+Cheng was a member of the executive council of the [[Ontario Psychiatric Association]] in 2005.((//Dialogue.// (2005, June). Ontario Psychiatric Association. https://web.archive.org/web/20220502040248/https://www.eopa.ca/sites/default/uploads/files/DialogueNL_June2005.pdf)) ((//Dialogue.// (2005, March). Ontario Psychiatric Association. https://web.archive.org/web/20220502040455/https://www.eopa.ca/sites/default/uploads/files/DialogueNL_Mar2005.pdf))
+At the time, sponsors for the OPA included [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Biovail]], [[pharmaceutical_companies:Eli Lilly]], [[pharmaceutical_companies:Genpharm]], [[pharmaceutical_companies:Lundbeckl]], [[pharmaceutical_companies:Organon]], [[pharmaceutical_companies:Shire]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], and [[pharmaceutical_companies:Wyeth]] (a [[pharmaceutical_companies:Pfizer]] company).
 ==== Northern Ontario School of Medicine ====
@@ Line 21: / Line 29: @@
 Her salary at St. Joseph's was $220,245.42 in 2019 and $252,330.60 in 2021.((//Public Salary Disclosure - St. Joseph’s Care Group - 2019.// St. Joseph’s Care Group. Retrieved May 1, 2022, from https://web.archive.org/web/20210325162058/https://www.sjcg.net/documents/accountability/salary-executive-contracts/salary/2019_Public-Sector-Salary-Disclosure_Bilingual.pdf)) ((//Public Salary Disclosure - St. Joseph’s Care Group 2021.// St. Joseph’s Care Group. Retrieved May 1, 2022, from https://web.archive.org/web/20220502014258/https://sjcg.net/documents/accountability/salary-executive-contracts/salary/2021_Public_Sector_Salary_Disclosure_Bilingual.pdf))
+She formerly worked as the medical director of the [[First Place Clinic and Regional Resource Centre]] under the [[Canadian Mental Health Association]].((//First Place Clinic and Regional Resource Centre.// (2016, November 4). Canadian Mental Health Association - Thunder Bay. https://archive.ph/VDr19))
+==== NorthBEAT ====
+In 2012, Cheng was awarded a 3-year New Investigator Research Award from the [[SickKids Foundation]] and [[Canadian Institutes of Health Research]] (CIHR) for The [[NorthBEAT]] Project.
+==== SickKids Foundation ====
+In 2017, Cheng served as a member of the New Investigator Program Grant Review Committee for the [[SickKids Foundation]].((//New Investigator Program Grant Review Committee September 2017.// (2017, September). Wayback Machine; SickKids Foundation. https://web.archive.org/web/20220502035214/https://www.sickkidsfoundation.com/-/media/files/skf/downloadable-resources/pdfs/about-us/grants/grc-members-list-2017.pdf))
 ==== Ontario COVID-19 Science Advisory Table ====
@@ Line 31: / Line 49: @@
 In February 2020, Cheng received the PSI-50 Mid-Career Clinical Research Award from the [[PSI Foundation]].((//PSI-50 Mid-Career Clinical Research Award - Dr. Chiachen Cheng.// (2020, February 18). PSI Foundation. https://www.psifoundation.org/psi-50-mid-career-clinical-research-award-dr-chiachen-cheng/))
+Cheng has co-authored research funded by the [[Canadian Pharmaceutical Association]] (CPhA, now the [[Canadian Pharmacists Association]]) and the [[Canadian Medical Association]] (CMA).((//Meta-analysis of benzodiazepine use in the treatment of insomnia.//
+Anne M. Holbrook, Renée Crowther, Ann Lotter, Chiachen Cheng, Derek King
+CMAJ Jan 2000, 162 (2) 225-233))